Literature DB >> 15532539

Salviae miltiorrhizae radix inhibits superoxide generation by activated rat microglias and mimics the action of amphetamine on in vitro rat striatal dopamine release.

Byung-Soo Koo1, Tae-Sig Kwon, Cheorl-Ho Kim.   

Abstract

Salviae miltiorrhizae Radix (SMR), an eminent herb in the treatment of cardiovascular disorder (called blood stasis in traditional Chinese medicine), is widely used in China, Japan, Taiwan and Korea. SMR is also herbal medicines used in the treatment of drug addiction without scientific support for their mechanism of action. We evaluated the effect of SMR on superoxide production by rat microglias using a 2-methyl-6-(p-methoxyphenyl)-3,7-dihydroimidazo[1,2-a]pyrazin-3-one-dependent chemiluminescence assay. SMR dose-dependently inhibited superoxide production by microglias stimulated with phorbol myristate acetate or opsonized zymosan, while it had no effect on superoxide production by a hypoxanthinexanthine oxidase system. These results indicate that SMR does not have a scavenging effect, but has an inhibitory effect on superoxide generation by microglias. Although SMR is commonly used for treating chronic cerebral infarction, it may also have a protective effect on progression of Parkinson's disease or Alzheimer's disease. On the other hand, the present study investigated the effect of the medicinal plant on dopaminergic neurotransmission in comparison with amphetamine. The effect of crude water extracts (0.1 g/ml) of SMR on K+ (20 mM)-stimulated dopamine release from rat striatal slices was compared with amphetamine (10(-4) M) using high-performance liquid chromatography with electrochemical detection to measure endogenous dopamine. Amphetamine and SMR significantly increased K+-stimulated dopamine release (P<0.001) from rat striatal slices when compared with K+-stimulated alone. SMR potentiated the effect of amphetamine on K+-stimulated dopamine release (P<0.001) when compared with amphetamine alone. The results indicate that SMR may stimulate dopamine release in the same manner as amphetamine. It remains to be determined whether the effect of this extract on dopamine function is important in its therapeutic use in the treatment of drug addiction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15532539     DOI: 10.1023/b:nere.0000042210.72927.ec

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  35 in total

Review 1.  Drugs of abuse and the brain.

Authors:  A I Leshner; G F Koob
Journal:  Proc Assoc Am Physicians       Date:  1999 Mar-Apr

2.  Nicergoline in mild to moderate dementia. A multicenter, double-blind, placebo-controlled study.

Authors:  A Battaglia; G Bruni; A Ardia; G Sacchetti
Journal:  J Am Geriatr Soc       Date:  1989-04       Impact factor: 5.562

Review 3.  The D3 dopamine receptor in cellular and organismal function.

Authors:  R A Shafer; B Levant
Journal:  Psychopharmacology (Berl)       Date:  1998-01       Impact factor: 4.530

4.  Chemiluminescence probe with Cypridina luciferin analog, 2-methyl-6-phenyl-3,7-dihydroimidazo[1,2-a]pyrazin-3-one, for estimating the ability of human granulocytes to generate O2-.

Authors:  M Nakano; K Sugioka; Y Ushijima; T Goto
Journal:  Anal Biochem       Date:  1986-12       Impact factor: 3.365

5.  MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease.

Authors:  I Kurkowska-Jastrzebska; A Wrońska; M Kohutnicka; A Członkowski; A Członkowska
Journal:  Acta Neurobiol Exp (Wars)       Date:  1999       Impact factor: 1.579

6.  Inhibitory effect of nicergoline on superoxide generation by activated rat microglias measured using a simple chemiluminescence method.

Authors:  T Yoshida; M Tanaka; K Okamoto
Journal:  Neurosci Lett       Date:  2001-01-05       Impact factor: 3.046

7.  Detection of superoxide production by activated microglia using a sensitive and specific chemiluminescence assay and microglia-mediated PC12h cell death.

Authors:  M Tanaka; A Sotomatsu; T Yoshida; S Hirai; A Nishida
Journal:  J Neurochem       Date:  1994-07       Impact factor: 5.372

8.  Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study.

Authors:  B Saletu; E Paulus; L Linzmayer; P Anderer; H V Semlitsch; J Grünberger; L Wicke; A Neuhold; I Podreka
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

9.  [Prevention of reperfusion injury of an ischemic flap: an experimental study].

Authors:  D P Yang
Journal:  Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi       Date:  1992-09

10.  [The effects of injection salviae miltiorrhizae in preventing and treating fat embolism syndrome].

Authors:  Z P Gu; C X Ma; B X Zhang
Journal:  Zhonghua Wai Ke Za Zhi       Date:  1994-11
View more
  3 in total

1.  Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction.

Authors:  Tsai-Hui Lin; Ching-Liang Hsieh
Journal:  Chin Med       Date:  2010-06-21       Impact factor: 5.455

2.  Myelophil, a mixture of Astragali Radix and Salviae Radix extract, moderates toxic side effects of fluorouracil in mice.

Authors:  Jang Woo Shin; Myong Min Lee; Jin Young Son; Nam Heon Lee; Chong Kwan Cho; Won Kyu Chung; Jung Hyo Cho; Chang Gue Son
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

3.  Salviae Miltiorrhizae BGE Radix increases rat striatal K(+)-stimulated dopamine release and activates the dopamine release with protection against hydrogen peroxide-induced injury in rat pheochromocytoma PC12 cells.

Authors:  Tae-Wook Chung; Byung-Soo Koo; Kyeong-Oh Kim; Hee-Sang Jeong; Min-Gon Kim; Kang-Hung Chung; In-Seon Lee; Cheorl-Ho Kim
Journal:  Neurochem Res       Date:  2006-01       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.